Baron Health Care Fund's Performance Impacted by Amgen (AMGN) Omission
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 1,577,866 | $555,172,536 | +75% | 0.19% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 108,330 | $38,115,793 | +4% | 0.26% |
| 3. | Lee Munder Capital Group Lee Munder | 34,497 | $12,137,905 | +1% | 0.72% |
| 4. | Navellier & Associates Louis Navellier | 11,971 | $4,212,102 | -4% | 0.44% |
| 5. | Zevenbergen Capital Investments Nancy Zevenbergen | 9,999 | $3,518,148 | +1% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | $1,655.00 | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | $499,907.10 | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | $99,919.25 | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $323.73 | 1,237 | $400,450.55 | 7,009 | 2026-05-04 | Filing | |
| $379.12 | 24,291 | $9,209,138.33 | 76,618 | 2026-02-26 | Filing | |
| $379.12 | 30,501 | $11,563,456.77 | 76,618 | 2026-02-26 | Filing | |
| $375.79 | 1,000 | $375,790.00 | 3,423 | 2026-02-19 | Filing | |
| $337.26 | 1,639 | $552,773.24 | 7,225 | 2025-11-20 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 35,014,232 | $12,319,757,530 | 0.31% | |
| 2. | 14,621,148 | $5,144,450,924 | 0.27% | |
| 3. | 3,870,863 | $1,361,963,156 | 0.31% | |
| 4. | 3,793,443 | $1,334,723,175 | 0.25% | |
| 5. | 3,304,344 | $1,162,649,382 | 0.24% |
News See All
Amgen Inc. (NASDAQ:AMGN) Q1 2026 Earnings Call Transcript
Operator: My name is Julianne, and I will be your conference facilitator today for the Amgen Inc. Q1 2026 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
Why Amgen Inc. (AMGN) is One of the Best Stem Cell Therapy Stocks to Buy
Amgen Inc. (NASDAQ:AMGN) is one of the best stem cell therapy stocks to buy. Canaccord initiated coverage of Amgen Inc. (NASDAQ:AMGN) with a Hold rating on April 21, setting a price target of $366.
8 Best Stem Cell Therapy Stocks to Buy
He stated that he is not surprised at the market resilience in the face of risk factors such as the war, oil prices, and inflation, looking at the behavior of the S&P 500 and the equity market more broadly...
Guggenheim Adjusts Amgen Inc. (AMGN) PT to $351, Cites Updated Model Ahead of Earnings
TheFly reported on April 9 that Guggenheim increased its price target on AMGN from $347 to $351 while maintaining a Neutral rating on the stock.
10 Most Undervalued Dow Stocks to Buy Now
The Dow Jones Industrial Average was established on May 26, 1896, as a straightforward benchmark to monitor market performance by author Charles Dow, who is a co-founder of Dow Jones & Co.
10 Healthcare Stocks with Highest Dividends
In December, CNBC reported that health-care job growth is propping up the labor market at a time when many other industries are struggling.
13 NASDAQ Stocks with Highest Dividends
In recent years, technology markets have drawn more attention from investors around the world, especially those linked to the NASDAQ Composite Index.
7 Most Profitable Value Stocks to Buy Right Now
On April 2, Kevin Mahn, Hennion & Walsh Asset Management president and chief investment officer, joined 'Squawk Box' on CNBC to discuss market reactions to developments in the Iran war.
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?
Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc.
Hedge Fund Resource Center